Despite Declining Quarterly Revenues, Lion s Bioinformatics Business Hits Profitability | GenomeWeb

NEW YORK, Nov. 3 (GenomeWeb News) - Lion Bioscience reported a 42-percent year-over-year decline in revenues for its second fiscal quarter today, but the company's bioinformatics business -- which is in the process of being sold to an undisclosed buyer -- posted a profit for the first time in Lion's history.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.